JP2007527913A5 - - Google Patents

Download PDF

Info

Publication number
JP2007527913A5
JP2007527913A5 JP2007502988A JP2007502988A JP2007527913A5 JP 2007527913 A5 JP2007527913 A5 JP 2007527913A5 JP 2007502988 A JP2007502988 A JP 2007502988A JP 2007502988 A JP2007502988 A JP 2007502988A JP 2007527913 A5 JP2007527913 A5 JP 2007527913A5
Authority
JP
Japan
Prior art keywords
independently selected
cycloalkyl
optionally substituted
halogen
substituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007502988A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007527913A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/007902 external-priority patent/WO2005086895A2/en
Publication of JP2007527913A publication Critical patent/JP2007527913A/ja
Publication of JP2007527913A5 publication Critical patent/JP2007527913A5/ja
Pending legal-status Critical Current

Links

JP2007502988A 2004-03-08 2005-03-07 イオンチャンネルモジュレーター Pending JP2007527913A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55137104P 2004-03-08 2004-03-08
PCT/US2005/007902 WO2005086895A2 (en) 2004-03-08 2005-03-07 Ion channel modulators

Publications (2)

Publication Number Publication Date
JP2007527913A JP2007527913A (ja) 2007-10-04
JP2007527913A5 true JP2007527913A5 (https=) 2008-04-24

Family

ID=34976220

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007502988A Pending JP2007527913A (ja) 2004-03-08 2005-03-07 イオンチャンネルモジュレーター

Country Status (8)

Country Link
US (2) US7368467B2 (https=)
EP (1) EP1722783A4 (https=)
JP (1) JP2007527913A (https=)
CN (1) CN1946397A (https=)
AU (1) AU2005221131A1 (https=)
BR (1) BRPI0508556A (https=)
CA (1) CA2557648A1 (https=)
WO (1) WO2005086895A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005087747A1 (en) * 2004-03-08 2005-09-22 Wyeth Ion channel modulators
WO2005086836A2 (en) * 2004-03-08 2005-09-22 Wyeth Ion channel modulators
AU2005221683A1 (en) * 2004-03-08 2005-09-22 Wyeth Ion channel modulators
EP1723123A4 (en) * 2004-03-08 2009-12-02 Wyeth Corp ION CHANNEL MODULATORS
EP2392328A1 (en) * 2005-05-09 2011-12-07 Hydra Biosciences, Inc. Compounds for modulating TRPV3 Function
US8916550B2 (en) * 2005-05-09 2014-12-23 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
US7893260B2 (en) * 2005-11-04 2011-02-22 Hydra Biosciences, Inc. Substituted quinazolin-4-one compounds for antagonizing TRPV3 function
US7998980B2 (en) 2006-09-15 2011-08-16 Hydra Biosciences, Inc. Compounds for modulating TRPV3 function
EP1939181A1 (en) * 2006-12-27 2008-07-02 sanofi-aventis Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase
WO2008140750A1 (en) * 2007-05-10 2008-11-20 Hydra Biosciences Inc. Compounds for modulating trpv3 function
TWI501965B (zh) 2008-06-20 2015-10-01 Lundbeck & Co As H 作為pde10a酵素抑制劑之新穎苯基咪唑衍生物
US8133897B2 (en) 2008-06-20 2012-03-13 H. Lundbeck A/S Phenylimidazole derivatives as PDE10A enzyme inhibitors
CN107375284B (zh) * 2008-08-26 2020-08-07 巴斯夫欧洲公司 冷薄荷醇受体trpm8的低分子量调节剂的检测和用途
CA2736117C (en) * 2008-09-04 2013-11-19 Ardea Biosciences, Inc. Compounds, compositions and methods of using same for modulating uric acid levels
AU2010221650B2 (en) * 2009-03-04 2015-06-25 Merck Sharp & Dohme Corp. Imidazole derivatives useful as modulators of FAAH and as FAAH imaging agents
WO2013054338A1 (en) * 2011-07-06 2013-04-18 Cadila Healthcare Limited 2-thio-imidazole derivatives as tgr5 modulators
WO2013102929A1 (en) * 2011-12-26 2013-07-11 Cadila Healthcare Limited Novel compounds for treatment of diabetes, obesity or related disorders
WO2014130550A1 (en) * 2013-02-20 2014-08-28 Allergan, Inc. Substituted diaryl derivatives as sphingosine receptor modulators
BR112017008594B1 (pt) * 2014-10-29 2023-04-18 Apoglyx Ab Derivados de 2-(1,2,4-triazol-3-ilsulfanil)-n-1,3,4-tiadiazol-2- il acetamida que são úteis para o tratamento de diabetes inter alia
WO2021154966A1 (en) 2020-01-29 2021-08-05 Kamari Pharma Ltd. Compounds and compositions for use in treating skin disorders
WO2023009347A1 (en) * 2021-07-30 2023-02-02 The Regents Of The University Of California Compounds for modulating epithelial 15-(s)-lipoxygenase-2 and methods of use for same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734421A (en) * 1986-10-29 1988-03-29 Merck & Co., Inc. Anti-inflammatory substituted 2-benzyl-mercapto-imidazole and pyrimidine derivatives compositions and method of use therefor
AU8757098A (en) 1997-06-30 1999-02-10 Ortho-Mcneil Pharmaceutical, Inc. 2-substituted imidazoles useful in the treatment of inflammatory diseases
US20030199523A1 (en) * 2002-02-28 2003-10-23 Snutch Terrance P. Heterocyclic calcium in channel blockers
WO2005086836A2 (en) * 2004-03-08 2005-09-22 Wyeth Ion channel modulators

Similar Documents

Publication Publication Date Title
JP2007527913A5 (https=)
CN105473576B (zh) 针对心脏病症的嘧啶二酮化合物
JP2010536761A5 (https=)
WO2009112678A3 (fr) Derives de carboxam i d es azabicycliques, leur preparation et leur application en therapeutique.
JP2007527919A5 (https=)
WO2009112677A3 (fr) Dérivés bicycliques de carboxamides azabicycliques, leur préparation et leur application en thérapeutique.
ES2264776T3 (es) Compuestos de aminociclohexil eter y sus usos.
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
WO2005018635A2 (en) Ion channel modulating activity i
TNSN07469A1 (en) N-(heteroaryl) -1- heteroarylalkyl -1h-indole-2- carboxamide derivatives, preparation and use thereof
SI2298768T1 (en) 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyridoS2,3-dCpyrimidine derivatives and related compounds for the treatment of cancer
EA200600990A1 (ru) Производные бензосульфониламинопиридин-2-ила и родственные соединения в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы 1 типа (11-бета-hsd-1) для лечения диабета и ожирения
JP2008214353A (ja) Peg化イオンチャネル調節化合物
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
JP6592512B2 (ja) 三環式アトロプ異性体の化合物
WO2011145669A1 (ja) アミド誘導体
EP2520566A1 (en) New Pharmaceutical Compounds
WO2010004221A3 (fr) Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
EP1386908A4 (en) AMINE DERIVATIVITY WITH CALIUM CHANNEL REGULATING FUNCTION, PRODUCTION AND USE THEREOF
NO320643B1 (no) Heterosykliske forbindelser
WO2007024843A3 (en) Pyrimidinyl-pyrazole inhibitors of aurora kinases
MX2010003393A (es) Composiciones de amida del acido indazol acrilico.
RU2008119994A (ru) Ингибиторы калиевых каналов
ATE466858T1 (de) 3-arylisoxazol-4-carbonylbenzofuranderivative
CN1976925A (zh) 吡咯基嘧啶erk蛋白激酶抑制剂的前体药物